第 1 到 69 筆結果,共 69 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2022 | A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma | WEI-WU CHEN ; CHIA-LANG HSU ; RUEY-LONG HONG ; JEN-CHIEH LEE ; Chang, Koping; CHIH-WEI YU ; Chen, San-Chi; JHE-CYUAN GUO ; Chen, Mei-Lu; Hsu, Meng-Chi; Kung, Ting-Fang; ANN-LII CHENG ; Yen, Chueh-Chuan | Clinical cancer research : an official journal of the American Association for Cancer Research | 6 | 6 | |
2 | 2022 | Short-course pembrolizumab and continuous afatinib therapy for recurrent or metastatic head and neck squamous cell carcinoma: a real-world data analysis | HSIANG-FONG KAO ; HUAI-CHENG HUANG ; BIN-CHI LIAO ; RUEY-LONG HONG | BMC cancer | 2 | 2 | |
3 | 2022 | Afatinib and Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (ALPHA Study): A Phase II Study with Biomarker Analysis | HSIANG-FONG KAO ; BIN-CHI LIAO ; YEN-LIN HUANG ; HUAI-CHENG HUANG ; Chun-Nan Chen ; TSENG-CHENG CHEN ; Hong, Yuan Jing; Chan, Ching Yi; JEAN-SAN CHIA ; RUEY-LONG HONG | Clinical Cancer Research | 33 | 28 | |
4 | 2022 | Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience | Wang, Yu-Wen; Tsai, Cheng-Hong ; HSIN-AN HOU ; FENG-MING TIEN ; JIA-HAU LIU ; WEN-CHIEN CHOU ; BOR-SHENG KO ; Chen, Yu-Wen; CHIEN-CHIN LIN ; Chieh-Lung Cheng ; Lo, Min-Yen; YUN-CHU LIN ; LI-CHUN LU ; SHANG-JU WU ; SUNG-HSIN KUO ; RUEY-LONG HONG ; TAI-CHUNG HUANG ; MING YAO | Annals of hematology | 10 | 9 | |
5 | 2022 | Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients | Blanchard P.; Lee A.W.M.; Carmel A.; Wai Tong N.; Ma J.; Chan A.T.C.; Hong R.L.; Chen M.-Y.; Chen L.; Li W.-F.; Huang P.-Y.; Kwong D.L.W.; Poh S.S.X.; Ngan R.; Mai H.-Q.; Ollivier C.; Fountzilas G.; Zhang L.; Bourhis J.; Aupérin A.; Lacas B.; Pignon J.-P.; Benhamou E.; Chakrabandhu S.; TC Chan A.; Chen Q.-Y.; Chen Y.; Chappell R.J.; Choi H.; TT Chua D.; Lee Kiang Chua M.; Higgins J.; Hong M.-H.; RUEY-LONG HONG ; Pun Hui E.; Hsiao C.F.; Kam M.; Angeliki Koliou G.; LW Kwong D.; Lai S.-C.; On Lam K.; LeBlanc M.L.; WM Lee A.; Fun Victor Lee H.; Fei Li W.; Ma B.; Mo F.; Moon J.; Tong Ng W.; O'Sullivan B.; Petit C.; Pierre Pignon J.; Poh S.X.; Rücker G.; Sham J.; Lim Soong Y.; Sun Y.; Tan T.; Tang L.-Q.; Tung Y.; Wee J.; Wu X.; Xu T.; Zhang Y.; Zhu G.; on behalf of the MAC-NPC collaborative Group | Clinical and Translational Radiation Oncology | 17 | 18 | |
6 | 2022 | Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048 | Rischin D.; Harrington K.J.; Greil R.; Soulières D.; Tahara M.; de Castro Jr G.; Psyrri A.; Braña I.; Neupane P.; Bratland Å.; Fuereder T.; Hughes B.G.M.; Mesía R.; Ngamphaiboon N.; Rordorf T.; Ishak W.Z.W.; RUEY-LONG HONG ; Mendoza R.G.; Jia L.; Chirovsky D.; Norquist J.; Jin F.; Burtness B. | Oral Oncology | 13 | 10 | |
7 | 2021 | A Clinicopathological Study of Cytomegalovirus Lymphadenitis and Tonsillitis and Their Association with Epstein–Barr Virus | SHAN-CHI YU ; KUAN-YIN KO ; SHU-CHUN TENG ; TAI-CHUNG HUANG ; Lo, Hsiao Ting; Chieh-Lung Cheng ; MING YAO ; RUEY-LONG HONG ; Chun-Nan Chen ; TSENG-CHENG CHEN ; TSUNG-LIN YANG | Infectious Diseases and Therapy | 1 | 2 | |
8 | 2020 | The impacts of intra-arterial chemotherapy on head and neck microvascular reconstruction | CHEN-HSIANG KUAN ; Chung M.-J.; RUEY-LONG HONG ; Tseng T.-Y.; HAO-CHIH TAI ; NAI-CHEN CHENG ; JUNG-HSIEN HSIEH ; SHYUE-YIH HORNG ; HONG-SHIEE LAI | Journal of the Formosan Medical Association | 2 | 1 | |
9 | 2020 | Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141) | Yen C.-J.; Kiyota N.; Hanai N.; Takahashi S.; Yokota T.; Iwae S.; Shimizu Y.; RUEY-LONG HONG ; Goto M.; Kang J.-H.; Li W.S.K.; Ferris R.L.; Gillison M.; Endo T.; Jayaprakash V.; Tahara M. | Head and Neck | 24 | 19 | |
10 | 2019 | Co-encapsulation of chlorin e6 and chemotherapeutic drugs in a pegylated liposome enhance the efficacy of tumor treatment: Pharmacokinetics and therapeutic efficacy | Po-Chun Peng; RUEY-LONG HONG ; Tsuimin Tsai; CHIN-TIN CHEN | Pharmaceutics | 12 | 10 | |
11 | 2019 | Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study | Burtness B.; Harrington K.J.; Greil R.; Souli?res D.; Tahara M.; de Castro G.; Jr, Psyrri A.; Bast? N.; Neupane P.; Bratland ?.; Fuereder T.; Hughes B.G.M.; Mes?a R.; Ngamphaiboon N.; Rordorf T.; Wan Ishak W.Z.; RUEY-LONG HONG ; Gonz?lez Mendoza R.; Roy A.; Zhang Y.; Gumuscu B.; Cheng J.D.; Jin F.; Rischin D.; Lerzo G.; Tatangelo M.; Varela M.; Zarba J.J.; Boyer M.; Gan H.; Gao B.; Hughes B.; Mallesara G.; Taylor A.; Burian M.; Barrios C.H.; de Castro Junior D.O.; Castro G.; Franke F.A.; Girotto G.; Lima I.P.F.; Nicolau U.R.; Pinto G.D.J.; Santos L.; Victorino A.-P.; Chua N.; Couture F.; Gregg R.; Hansen A.; Hilton J.; McCarthy J.; Soulieres D.; Ascui R.; Gonzalez P.; Villanueva L.; Torregroza M.; Zambrano A.; Holeckova P.; Kral Z.; Melichar B.; Prausova J.; Vosmik M.; Andersen M.; Gyldenkerne N.; Jurgens H.; Putnik K.; Reinikainen P.; Gruenwald V.; Laban S.; Aravantinos G.; Boukovinas I.; Georgoulias V.; Kwong D.; Al-Farhat Y.; Csoszi T.; Erfan J.; Horvai G.; Landherr L.; Remenar E.; Ruzsa A.; Szota J.; Billan S.; Gluck I.; Gutfeld O.; Popovtzer A.; Benasso M.; Bui S.; Ferrari V.; Licitra L.; Nole F.; Fujii T.; Fujimoto Y.; Hanai N.; Hara H.; Matsumoto K.; Mitsugi K.; Monden N.; Nakayama M.; Okami K.; Oridate N.; Shiga K.; Shimizu Y.; Sugasawa M.; Takahashi M.; Takahashi S.; Tanaka K.; Ueda T.; Yamaguchi H.; Yamazaki T.; Yasumatsu R.; Yokota T.; Yoshizaki T.; Kudaba I.; Stara Z.; Cheah S.K.; Aguilar Ponce J.; Gonzalez Mendoza R.; Hernandez Hernandez C.; Medina Soto F.; Buter J.; Hoeben A.; Oosting S.; Suijkerbuijk K.; Bratland A.; Brydoey M.; Alvarez R.; Mas L.; Caguioa P.; Querol J.; Regala E.E.; Tamayo M.B.; Villegas E.M.; Kawecki A.; Karpenko A.; Klochikhin A.; Smolin A.; Zarubenkov O.; Goh B.C.; Cohen G.; du Toit J.; Jordaan C.; Landers G.; Ruff P.; Szpak W.; Tabane N.; Brana I.; Iglesias Docampo L.; Lavernia J.; Mesia R.; Abel E.; Muratidu V.; Nielsen N.; Cristina V.; Rothschild S.; Wang H.-M.; Yang M.-H.; Yeh S.-P.; Yen C.-J.; Soparattanapaisarn N.; Sriuranpong V.; Aksoy S.; Cicin I.; Ekenel M.; Harputluoglu H.; Ozyilkan O.; Harrington K.; Agarwala S.; Ali H.; Alter R.; Anderson D.; Bruce J.; Campbell N.; Conde M.; Deeken J.; Edenfield W.; Feldman L.; Gaughan E.; Goueli B.; Halmos B.; Hegde U.; Hunis B.; Jotte R.; Karnad A.; Khan S.; Laudi N.; Laux D.; Martincic D.; McCune S.; McGaughey D.; Misiukiewicz K.; Mulford D.; Nadler E.; Nunnink J.; Ohr J.; O'Malley M.; Patson B.; Paul D.; Popa E.; Powell S.; Redman R.; Rella V.; Rocha Lima C.; Sivapiragasam A.; Su Y.; Sukari A.; Wong S.; Yilmaz E.; Yorio J. | The Lancet | 1642 | 1531 | |
12 | 2019 | Primary intradural extramedullary spinal mesenchymal chondrosarcoma: Case report and literature review | CHIH-WEI CHEN ; Chen I.-H.; MING-HSIAO HU ; JEN-CHIEH LEE ; Huang H.-Y.; RUEY-LONG HONG ; SHU-HUA YANG | BMC Musculoskeletal Disorders | 8 | 7 | |
13 | 2019 | Prognostic factors and treatment outcomes of adult patients with rhabdomyosarcoma after multimodality treatment | Liu Y.-T.; CHUN-WEI WANG ; RUEY-LONG HONG ; SUNG-HSIN KUO | Anticancer Research | 14 | 11 | |
14 | 2018 | Pembrolizumab for the treatment of advanced salivary gland carcinoma | Cohen R.B.; Delord J.-P.; Doi T.; Piha-Paul S.A.; Liu S.V.; Gilbert J.; Algazi A.P.; Damian S.; RUEY-LONG HONG ; Le Tourneau C.; Day D.; Varga A.; Elez E.; Wallmark J.; Saraf S.; Thanigaimani P.; Cheng J.; Keam B. | American Journal of Clinical Oncology: Cancer Clinical Trials | 148 | 119 | |
15 | 2018 | A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell Killing | Lizotte P.H.; RUEY-LONG HONG ; Luster T.A.; Cavanaugh M.E.; Taus L.J.; Wang S.; Dhaneshwar A.; Mayman N.; Yang A.; Kulkarni M.; Badalucco L.; Fitzpatrick E.; HSIANG-FONG KAO ; Kuraguchi M.; Bittinger M.; Kirschmeier P.T.; Gray N.S.; Barbie D.A.; Janne P.A. | Cancer Immunology Research | 57 | 53 | |
16 | 2018 | Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study | RUEY-LONG HONG ; Hsiao C.F.; Ting L.L.; JENG-YUH KO ; CHUN-WEI WANG ; Chang J.T.C.; PEI-JEN LOU ; Wang H.M.; Tsai M.H.; Lai S.C.; Liu T.W. | Annals of Oncology | 98 | 92 | |
17 | 2017 | Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma | JENNY LING-YU CHEN ; YU-SEN HUANG ; SUNG-HSIN KUO ; RUEY-LONG HONG ; JENG-YUH KO ; PEI-JEN LOU ; CHUN-WEI WANG | Oncotarget | 17 | 15 | |
18 | 2017 | Terminally Ill Taiwanese Cancer Patients’ and Family Caregivers’ Agreement on Patterns of Life-Sustaining Treatment Preferences Is Poor to Fair and Declines Over a Decade: Results From Two Independent Cross-Sectional Studies | Liu T.-W.; Wen F.-H.; Wang C.-H.; RUEY-LONG HONG ; Chow J.-M.; Chen J.-S.; Chiu C.-F.; Tang S.T. | Journal of Pain and Symptom Management | 17 | 16 | |
19 | 2017 | Histone methyltransferase G9a drives chemotherapy resistance by regulating the glutamate-cysteine ligase catalytic subunit in head and neck squamous cell carcinoma | Liu C.-W.; KUO-TAI HUA ; Li K.-C.; HSIANG-FONG KAO ; RUEY-LONG HONG ; JENG-YUH KO ; Hsiao M.; Kuo M.-L.; CHING-TING TAN | Molecular Cancer Therapeutics | 42 | 40 | |
20 | 2017 | A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator's choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141 | Kiyota N.; Hasegawa Y.; Takahashi S.; Yokota T.; Yen C.-J.; Iwae S.; Shimizu Y.; RUEY-LONG HONG ; Goto M.; Kang J.-H.; Sum Kenneth Li W.; Ferris R.L.; Gillison M.; Namba Y.; Monga M.; Lynch M.; Tahara M. | Oral Oncology | 79 | 69 | |
21 | 2017 | Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for Stage I/II nasal extranodal NK/T-cell lymphoma | WEN-CHI YANG ; CHUN-WEI WANG ; RUEY-LONG HONG ; CHIAO-LING TSAI ; MING YAO ; JIH-LUH TANG ; CHUNG-WU LIN ; ANN-LII CHENG ; SUNG-HSIN KUO | Journal of Radiation Research | 9 | 9 | |
22 | 2015 | α-Enolase-binding peptide enhances drug delivery efficiency and therapeutic efficacy against colorectal cancer | Wu C.-H.; Kuo Y.-H.; RUEY-LONG HONG ; Wu H.-C. | Science Translational Medicine | 48 | 27 | |
23 | 2015 | Nasopharyngeal Carcinoma and Pulmonary Lymphoepithelioma-like Carcinoma-Metastases or Synchronous Second Primary Cancer | MING-KAI CHUANG ; RUEY-LONG HONG | Journal of Cancer Research and Practice | 0 | 0 | |
24 | 2015 | Dual-effect liposomes encapsulated with doxorubicin and chlorin e6 augment the therapeutic effect of tumor treatment | Peng P.-C.; RUEY-LONG HONG ; Tsai Y.-J.; Li P.-T.; Tsai T.; Chen C.-T. | Lasers in Surgery and Medicine | 32 | 32 | |
25 | 2013 | Pemetrexed in combination with cisplatin versus cisplatin monotherapy in East Asian patients with recurrent or metastatic head and neck cancer: Results of an exploratory subgroup analysis of a phase III trial | Urba S.; RUEY-LONG HONG ; Hossain A.M.; Cheng R.; Orlando M. | Asia-Pacific Journal of Clinical Oncology | 1 | 1 | |
26 | 2013 | Identification of novel mutations of TP53, ALK and RET gene in metastatic thymic squamous cell carcinoma and its therapeutic implication | Hu Z.; Wang J.; Yao T.; RUEY-LONG HONG ; Zhang K.; Gao H.; Wu X.; Li J.; Bai C.; Yen Y. | Lung Cancer | 6 | 6 | |
27 | 2013 | Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma: Treatment results and locoregional recurrence | JENNY LING-YU CHEN ; YU-SEN HUANG ; SUNG-HSIN KUO ; YA-FANG CHEN ; RUEY-LONG HONG ; JENG-YUH KO ; PEI-JEN LOU ; CHIAO-LING TSAI ; WAN-YU CHEN ; CHUN-WEI WANG | Strahlentherapie und Onkologie | 26 | 24 | |
28 | 2013 | An international collaboration to harmonize the quantitative plasma Epstein-Barr virus DNA assay for future biomarker-guided trials in nasopharyngeal carcinoma | Le Q.-T.; Zhang Q.; Cao H.; Cheng A.-J.; Pinsky B.A.; RUEY-LONG HONG ; Chang J.T.; CHUN-WEI WANG ; Tsao K.-C.; Lo Y.M.D.; Lee N.; Ang K.K.; Chan A.T.C.; Chan K.C.A. | Clinical Cancer Research | 135 | 119 | |
29 | 2012 | Factors impacting prognosis prediction in BCLC stage C and Child-Pugh Class A hepatocellular carcinoma patients in prospective clinical trials of systemic therapy | ZHONG-ZHE LIN ; CHIUN HSU ; Hu F.-C.; YU-YUN SHAO ; DWANG-YING CHANG ; CHIH-HSIN YANG ; RUEY-LONG HONG ; CHIH-HUNG HSU ; ANN-LII CHENG | Oncologist | 8 | 10 | |
30 | 2012 | Clinicopathological features of salivary and non-salivary adenoid cystic carcinomas | Lin Y.-C.; Chen K.-C.; CHING-HUNG LIN ; KUAN-TING KUO ; JENG-YUH KO ; RUEY-LONG HONG | International Journal of Oral and Maxillofacial Surgery | 22 | 19 | |
31 | 2012 | Osteoradionecrosis of the upper cervical spine after radiation therapy for head and neck cancer: Differentiation from recurrent or metastatic disease with MR imaging | Wu L.-A.; HON-MAN LIU ; CHUN-WEI WANG ; YA-FANG CHEN ; RUEY-LONG HONG ; JENG-YUH KO | Radiology | 22 | 20 | |
32 | 2012 | Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: Final results of a randomized, double-blind, placebo-controlled, phase 3 study | Urba S.; Van Herpen C.M.L.; Sahoo T.P.; Shin D.M.; Licitra L.; Mezei K.; Reuter C.; Hitt R.; Russo F.; Chang S.-C.; Hossain A.M.; Frimodt-Moller B.; Koustenis A.; RUEY-LONG HONG | Cancer | 38 | 30 | |
33 | 2012 | Postoperative intensity-modulated radiotherapy for squamous cell carcinoma of the external auditory canal and middle ear: Treatment outcomes, marginal misses, and perspective on target delineation | WAN-YU CHEN ; SUNG-HSIN KUO ; YU-HSUAN CHEN ; Lu S.-H.; CHIAO-LING TSAI ; CHIA-HSIEN CHENG ; RUEY-LONG HONG ; YA-FANG CHEN ; Hsu C.-J.; Lin K.-N.; JENG-YUH KO ; PEI-JEN LOU ; CHENG-PING WANG ; Chong F.-C.; CHUN-WEI WANG | International Journal of Radiation Oncology Biology Physics | 13 | 12 | |
34 | 2012 | Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer | Chua D.T.T.; Yiu H.H.-Y.; Seetalarom K.; Ng A.W.-Y.; Kurnianda J.; Shotelersuk K.; Krishnan G.; RUEY-LONG HONG ; Yang M.-H.; Wang C.-H.; Sze W.-K.; Ng W.-T. | Head and Neck | 33 | 32 | |
35 | 2012 | A phase I and pharmacokinetic study of liposomal vinorelbine in patients with advanced solid tumor | SHIH-HUNG YANG ; CHIA-CHI LIN ; ZHONG-ZHE LIN ; Tseng Y.-L.; RUEY-LONG HONG | Investigational New Drugs | 34 | 28 | |
36 | 2010 | The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients | RUOH-FANG YEN ; Chen C.-Y.; MEI-FANG CHENG ; YEN-WEN WU ; Shiau Y.-C.; Wu K.; RUEY-LONG HONG ; CHONG-JEN YU ; Wang K.-L.; RONG-SEN YANG | Nuclear Medicine Communications | 51 | 40 | |
37 | 2010 | Pleural metastases as a unique entity with dismal outcome of head and neck squamous cell carcinoma | YU-YUN SHAO ; RUEY-LONG HONG | Oral Oncology | 6 | 7 | |
38 | 2009 | Nasion swelling as the presenting symptom of lung adenocarcinoma | CHUN-TA HUANG ; RUEY-LONG HONG | Journal of Thoracic Oncology | 9 | 9 | |
39 | 2009 | The Cost-utility Analysis of 18-Fluoro-2-Deoxyglucose Positron Emission Tomography in the Diagnosis of Recurrent Nasopharyngeal Carcinoma | RUOH-FANG YEN ; Yen M.-F.; RUEY-LONG HONG ; KAI-YUAN TZEN ; Chien C.-R.; Chen, Tony Hsiu Hsi | Academic Radiology | 23 | 21 | |
40 | 2009 | Usefulness of 201Tl spect/CT relative to 18F-FDG PET/CT in detecting recurrent skull base nasopharyngeal carcinoma | RUOH-FANG YEN ; Ting L.-L.; MEI-FANG CHENG ; YEN-WEN WU ; KAI-YUAN TZEN ; RUEY-LONG HONG | Head and Neck | 6 | 8 | |
41 | 2008 | A phase-I study evaluating the combination of pegylated liposomal doxorubicin and paclitaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracycline | RUEY-LONG HONG ; CHING-HUNG LIN ; Chao T.-Y.; Kao W.-Y.; Wang C.-H.; Hsieh R.K.; Hwang W.-S. | Cancer Chemotherapy and Pharmacology | 9 | 7 | |
42 | 2008 | Fatal thrombocytopenia after oxaliplatin-based chemotherapy | YU-YUN SHAO ; RUEY-LONG HONG | Anticancer Research | 19 | 20 | |
43 | 2006 | Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma | Wang C.-C.; Chang J.-Y.; Liu T.-W.; Lin C.-Y.; Yu Y.-C.; RUEY-LONG HONG | Head and Neck | 51 | 46 | |
44 | 2006 | Difference in the incidence trend of nasopharyngeal and oropharyngeal carcinomas in Taiwan: Implication from age-period-cohort analysis | CHIUN HSU ; Ying-Chun Shen ; Cheng C.-C.; RUEY-LONG HONG ; Chang C.-J.; ANN-LII CHENG | Cancer Epidemiology Biomarkers and Prevention | 67 | 51 | |
45 | 2005 | Unexpected rapid progression of metastatic adenoid cystic carcinoma during treatment with imatinib mesylate | CHING-HUNG LIN ; RUOH-FANG YEN ; YUNG-MING JENG ; Tzen C.-Y.; CHIUN HSU ; RUEY-LONG HONG | Head and Neck | 40 | 30 | |
46 | 2005 | Early restaging whole-body 18F-FDG PET during induction chemotherapy predicts clinical outcome in patients with locoregionally advanced nasopharyngeal carcinoma | RUOH-FANG YEN ; Chen, Tony Hsiu Hsi ; Ting L.-L.; KAI-YUAN TZEN ; Pan M.-H.; RUEY-LONG HONG | European Journal of Nuclear Medicine and Molecular Imaging | 45 | 38 | |
47 | 2005 | Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma | Chan A.T.C.; Hsu M.-M.; Goh B.C.; Hui E.P.; Liu T.-W.; Millward M.J.; RUEY-LONG HONG ; Whang-Peng J.; Ma B.B.Y.; To K.F.; Mueser M.; Amellal N.; Lin X.; Chang A.Y. | Journal of Clinical Oncology | 261 | 217 | |
48 | 2005 | Response of refractory osteosarcoma to thalidomide and celecoxib | YU-CHIEH TSAI ; CHEN-TU WU ; RUEY-LONG HONG | Lancet Oncology | 15 | 14 | |
49 | 2005 | Whole-body 18F-FDG PET in recurrent or metastatic nasopharyngeal carcinoma | RUOH-FANG YEN ; RUEY-LONG HONG ; KAI-YUAN TZEN ; Pan M.-H.; HSIU-HSI CHEN | Journal of Nuclear Medicine | 52 | 41 | |
50 | 2004 | Treatment Outcome and Pattern of Failure in 77 Patients with Sinonasal Natural Killer/T-Cell or T-Cell Lymphoma | Li C.-C.; HWEI-FANG TIEN ; JIH-LUH TANG ; MING YAO ; YAO-CHANG CHEN ; Su I.-J.; Hsu S.-M.; RUEY-LONG HONG | Cancer | 168 | 142 | |
51 | 2004 | Effect of 5-Aminolevulinic Acid-Mediated Photodynamic Therapy on MCF-7 and MCF-7/ADR Cells | Tsai, Tsuimin; RUEY-LONG HONG ; JUI-CHANG TSAI ; PEI-JEN LOU ; Ling, I-Fang; Chen, Chin-Tin | Lasers in Surgery and Medicine | 76 | 62 | |
52 | 2004 | Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNA | RUEY-LONG HONG ; Lin C.-Y.; Ting L.-L.; JENG-YUH KO ; Hsu M.-M. | Cancer | 46 | 36 | |
53 | 2004 | Recent advances in the treatment of nasopharyngeal carcinoma | Chang J.T.-C.; JENQ-YUH KO ; RUEY-LONG HONG | Journal of the Formosan Medical Association | |||
54 | 2003 | Clinicopathologic characteristics and prognoses of gastric cancer in patients with a positive familial history of cancer | Lee, Wei-Jei; RUEY-LONG HONG ; I-RUE LAI ; CHIUNG-NIEN CHEN ; PO-HUANG LEE ; Huang, Ming-Tegh | Journal of clinical gastroenterology | 23 | 19 | |
55 | 2003 | A phase II and pharmacokinetic study of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma | RUEY-LONG HONG ; Tseng Y.-L. | Cancer Chemotherapy and Pharmacology | 41 | 38 | |
56 | 2003 | Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma | SHANG-YI HUANG ; JIH-LUH TANG ; MING YAO ; BOR-SHENG KO ; RUEY-LONG HONG ; Tsai W.; Wang C.-H.; HWEI-FANG TIEN ; MING-CHING SHEN ; YAO-CHANG CHEN | Annals of Hematology | 12 | 10 | |
57 | 2003 | Quality of life in patients of nasopharyngeal carcinoma: Validation of the Taiwan Chinese version of the EORTC QLQ-C30 and the EORTC QLQ-H&N35 | WEI-CHU CHIE ; RUEY-LONG HONG ; Lai C.-C.; Ting L.-L.; Hsu M.-M. | Quality of Life Research | 88 | 76 | |
58 | 2002 | Alterations of BAT-26 identify a subset of gastric cancer with distinct clinicopathologic features and better postoperative prognosis | MING-SHIANG WU ; Lee C.-W.; JIN-CHUAN SHEU ; CHIA-TUNG SHUN ; HSIU-PO WANG ; RUEY-LONG HONG ; Lee W.-J.; Lin J.-T. | Hepato-Gastroenterology | 22 | 21 | |
59 | 2002 | Simple and efficient liposomal encapsulation of topotecan by ammonium sulfate gradient: Stability, pharmacokinetic and therapeutic evaluation | Liu J.-J.; RUEY-LONG HONG ; WEN-FANG CHENG ; Hong K.; FU-HSIUNG CHANG ; Tseng Y.-L. | Anti-Cancer Drugs | 38 | 35 | |
60 | 2002 | Reappraisal of the new UICC staging system for gastric cancer: Problem in lymph node stage | Lee W.-J.; RUEY-LONG HONG ; I-RUE LAI ; Chen C.-N.; PO-HUANG LEE ; Chung K.-C. | Hepato-Gastroenterology | 14 | 12 | |
61 | 2002 | Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and Tat: A kinetic and efficacy study | Tseng Y.-L.; Liu J.-J.; RUEY-LONG HONG | Molecular Pharmacology | 218 | 205 | |
62 | 2002 | Prognostic value of multidrug resistance 1, glutathione-S-transferase-π and p53 in advanced nasopharyngeal carcinoma treated with systemic chemotherapy | CHIH-HUNG HSU ; Chen C.-L.; RUEY-LONG HONG ; Chen K.-L.; Lin J.-F.; ANN-LII CHENG | Oncology | 31 | 25 | |
63 | 2001 | Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 cases | Hsu M.-M; RUEY-LONG HONG ; Ting L.-L; JENG-YUH KO ; Sheen T.-S; PEI-JEN LOU | Archives of Otolaryngology - Head and Neck Surgery | 50 | 43 | |
64 | 2001 | Anaphylaxis after propocol infusion for Port-A-Cath insertion in a 35-year old man | Tsai M.-H.; PING-HUNG KUO ; RUEY-LONG HONG ; PAN-CHYR YANG | Journal of the Formosan Medical Association | 13 | 12 | |
65 | 2001 | Construction of single-chain interleukin-12 DNA plasmid to treat airway hyperresponsiveness in an animal model of asthma | Lee Y.-L.; Ye Y.-L.; Yu C.-I.; Wu Y.-L.; Lai Y.-L.; Ku P.-H.; RUEY-LONG HONG ; BOR-LUEN CHIANG | Human Gene Therapy | 41 | 38 | |
66 | 2001 | Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma | RUEY-LONG HONG ; Ting L.-L.; JENG-YUH KO ; Hsu M.-M.; Sheen T.-S.; PEI-JEN LOU ; CHIA-CHUN WANG ; Chung N.-N.; Lui L.T. | Journal of Clinical Oncology | 96 | 86 | |
67 | 2001 | Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumors: The relation between pharmacokinetic property and toxicity | RUEY-LONG HONG ; Tseng Y.-L. | Cancer | 81 | ||
68 | 2000 | Pegylated liposomal doxorubicin in treating a case of advanced hepatocellular carcinoma with severe hepatic dysfunction and pharmacokinetic study | RUEY-LONG HONG ; Tseng Y.-L.; FU-HSIUNG CHANG | Annals of Oncology | 22 | 19 | |
69 | 2000 | DNA content of nasopharyngeal carcinoma: An independent prognostic indicator | Hsu M.-M; Chiou C.-R; JENG-YUH KO ; Sheen T.-S; RUEY-LONG HONG ; Ting L.-L. | Cancer Detection and Prevention |